Dror Ortho-Design, Inc. Files Amendment No. 1 to Form 10-K for Fiscal Year Ended Dec 31, 2023

Ticker: DROR · Form: 10-K/A · Filed: Apr 25, 2024 · CIK: 1282980

Sentiment: neutral

Topics: 10-K/A, Amendment, Dror Ortho-Design, Fiscal Year End, SEC Filing

TL;DR

<b>Dror Ortho-Design, Inc. has filed an amendment to its 2023 annual report, providing updated information and confirming its status as a smaller reporting company.</b>

AI Summary

Dror Ortho-Design, Inc. (DROR) filed a Amended Annual Report (10-K/A) with the SEC on April 25, 2024. Dror Ortho-Design, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ending December 31, 2023. The company is incorporated in Delaware and has its principal executive office in Jerusalem, Israel. Dror Ortho-Design, Inc. was formerly known as Novint Technologies, Inc., with a name change date of March 8, 2004. The company is classified as a non-accelerated filer and a smaller reporting company. No securities are registered pursuant to Section 12(b) of the Act, and common stock is registered pursuant to Section 12(g).

Why It Matters

For investors and stakeholders tracking Dror Ortho-Design, Inc., this filing contains several important signals. This amendment indicates that the company is providing updated or corrected information for its 2023 fiscal year, which could be material for investors assessing its current financial health and operational status. The classification as a smaller reporting company suggests that Dror Ortho-Design, Inc. may have less stringent disclosure requirements compared to larger filers, which is important context for analyzing the depth of information provided.

Risk Assessment

Risk Level: low — Dror Ortho-Design, Inc. shows low risk based on this filing. The filing is an amendment to a 10-K, which is a routine update for a fiscal year-end report, and does not indicate any immediate or significant new risks.

Analyst Insight

Review the specific changes made in Amendment No. 1 to the 10-K filing to understand any updated financial or operational details for Dror Ortho-Design, Inc.

Key Numbers

Key Players & Entities

FAQ

When did Dror Ortho-Design, Inc. file this 10-K/A?

Dror Ortho-Design, Inc. filed this Amended Annual Report (10-K/A) with the SEC on April 25, 2024.

What is a 10-K/A filing?

A 10-K/A is a amendment to a previously filed annual report, correcting or updating financial statements or disclosures. This particular 10-K/A was filed by Dror Ortho-Design, Inc. (DROR).

Where can I read the original 10-K/A filing from Dror Ortho-Design, Inc.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Dror Ortho-Design, Inc..

What are the key takeaways from Dror Ortho-Design, Inc.'s 10-K/A?

Dror Ortho-Design, Inc. filed this 10-K/A on April 25, 2024. Key takeaways: Dror Ortho-Design, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ending December 31, 2023.. The company is incorporated in Delaware and has its principal executive office in Jerusalem, Israel.. Dror Ortho-Design, Inc. was formerly known as Novint Technologies, Inc., with a name change date of March 8, 2004..

Is Dror Ortho-Design, Inc. a risky investment based on this filing?

Based on this 10-K/A, Dror Ortho-Design, Inc. presents a relatively low-risk profile. The filing is an amendment to a 10-K, which is a routine update for a fiscal year-end report, and does not indicate any immediate or significant new risks.

What should investors do after reading Dror Ortho-Design, Inc.'s 10-K/A?

Review the specific changes made in Amendment No. 1 to the 10-K filing to understand any updated financial or operational details for Dror Ortho-Design, Inc. The overall sentiment from this filing is neutral.

How does Dror Ortho-Design, Inc. compare to its industry peers?

The company operates in the Dental Equipment & Supplies industry (SIC 3843).

Are there regulatory concerns for Dror Ortho-Design, Inc.?

The filing is made under the Securities Exchange Act of 1934, requiring annual reports and amendments for public companies.

Industry Context

The company operates in the Dental Equipment & Supplies industry (SIC 3843).

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, requiring annual reports and amendments for public companies.

What Investors Should Do

  1. Analyze the specific amendments made in this 10-K/A filing.
  2. Verify the company's current operational status and financial reporting compliance.
  3. Research the company's industry and market position within dental equipment and supplies.

Key Dates

Year-Over-Year Comparison

This is an amendment to the previously filed 10-K for the fiscal year ended December 31, 2023. Specific details of the changes from the original filing are not provided in this header information.

Filing Stats: 1,316 words · 5 min read · ~4 pages · Grade level 12.8 · Accepted 2024-04-25 16:30:07

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES 3 i Explanatory Note This Amendment No. 1 to our Annual Report on Form 10-K (this "Amendment") amends the Annual Report on Form 10-K for the fiscal year ended December 31, 2023 of Dror Ortho-Design, Inc. (f/k/a Novint Technologies, Inc.) ("we," "us," "Dror," or the "Company"), as originally filed with the Securities and Exchange Commission on April 1, 2024 (the "Form 10-K"). We are filing this Amendment (1) to amend the cover page to state that the Company's common stock is registered under Section 12(g) of the Exchange Act of 1934, as amended and (2) to amend Item 5 of the Form 10-K to disclose an additional issuance unregistered securities that was inadvertently omitted from the Form 10-K. In addition, Item 15 of Part IV has been amended solely to include a new certification by our principal executive officer and principal financial officer pursuant to Section 302 of the Sarbanes–Oxley Act of 2002. The certification of our principal executive officer and principal financial officer is filed with this Amendment as Exhibit 31.1 hereto. Because no financial statements have been included in this Amendment and this Amendment does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4 and 5 of the certification have been omitted. Additionally, we are not including the certificate under Section 906 of the Sarbanes–Oxley Act of 2002 as no financial statements are being filed with this Amendment. Except as otherwise expressly noted herein, this Amendment does not modify or update in any way the Form 10-K, nor does it reflect events occurring after the filing of the Form 10-K. Accordingly, this Amendment should be read in conjunction with the Form 10-K. ii PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. Recent Sales of Unregistered Securities During the fiscal year ended December 31, 2023, all sales of equity securitie

financial statements are filed with this Amendment. These items were included as part of the Form 10-K

financial statements are filed with this Amendment. These items were included as part of the Form 10-K. (2) Financial Statement Schedules: None. (3) Exhibits: Exhibit No. Description 31.1* Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 104* Cover Page Interactive Data File (embedded within the Inline XBRL document) * Filed herewith. 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DROR ORTHO-DESIGN, INC. Date: April 25, 2024 By: /s/ Eliyahu (Lee) Haddad Name: Eliyahu (Lee) Haddad Title: Chief Executive Officer (Principal Executive Officer and Principal Financial and Accounting Officer) 3

View Full Filing

View this 10-K/A filing on SEC EDGAR

View on Read The Filing